Skip to content
KLOW Index

A gunmetal data-console reading of the four-peptide KLOW research record — KPV, GHK-Cu, BPC-157 and TB-500 logged as four channels on one dense instrument panel, the component literature tabulated and the blend's missing combination data flagged as a null row.

STUDY AMOUNTS // NO HUMAN PLAN

KLOW Peptide Dosage: What Can the Numbers Tell You?

The vial has 80 mg in a 50/10/10/10 ratio. Amounts from separate tests can't give you a plan.

What do the test amounts tell you?

You don't have a tested human dose for the KLOW blend. The usual 80 mg vial contains GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, and KPV 10 mg. Those numbers tell you what comes in the vial. They don't give you an amount or a time for use.

Each peptide, a short chain of protein parts, was studied on its own, not in your body. Tests used different amounts, animals, and ways of giving it. You can't add those amounts and call the sum a KLOW dose. The amounts below come straight from the papers. It isn't a dosing plan, and it gives no daily amount.

You can use these figures to judge a claim. They can't tell you what to take.

KLOW peptide dosage — what does the 80 mg mean?

The research vial most often listed has this mix:

partAmount in milligramsShare of the vial
GHK-Cu50~62.5%
BPC-15710~12.5%
TB-50010~12.5%
KPV10~12.5%
Total80100%

GHK-Cu makes up about ~62.5% of the weight. You won't find an FDA-approved drug with this mix. An official drug book doesn't list it. The 80 mg/vial amount is common in the research trade, but it isn't a proved dose.

The vial weight isn't your daily amount. Its label can't give you a dose.

What amount did each separate study use?

KPV in key studies [3][9]:

  • A dish test used 10 nanomoles, a lab count of bits too small to see. KPV lowered signs that drive swelling in human bowel cells and T cells.
  • Mice with sore, swollen colons drank 100 micromoles. That lab count was made for the test, and their colons improved.
  • The mouse test gave KPV by mouth. A natural carrier then moved it into sore bowel cells.

GHK-Cu in key studies [4][5]:

  • Cells got 1-10 nanomoles, another count made only for lab work. The cells changed which proteins they made and produced more early collagen.
  • Human work used skin products. The amount changed by product and study.
  • Tests used skin cream or lab-grown cells. No human trial has set an injected amount.

BPC-157 in key studies [2][6][8]:

  • Rat tendon tests put 10 millionths, 10 billionths, or 10 trillionths of a gram into each rat's belly once daily.
  • Rat stomach tests used 400 billionths of a gram per kilogram and 800 billionths of a gram per kilogram into muscle or put it into the stomach.
  • A 2025 human safety check used 10 mg on day 1 and 20 mg on day 2. Two adults got it by vein in 250 mL of salt water over 1 hour [6]. No bad events were seen.
  • One rat study found it in the blood for under about 30 minutes, so it left fast.
  • You won't find an FDA-approved amount for people.

TB-500 and the full protein in a key study [1]:

  • A rat wound test put the full natural protein on the skin or into the belly. It didn't use the TB-500 piece.
  • Just 10 trillionths of a gram helped skin cells move 2-3-fold in a dish.
  • The test put the whole natural protein on skin and into the belly. Amounts for the short TB-500 piece aren't set on their own.
  • There is no tested human amount for the TB-500 piece.

Each figure answers a test question. It doesn't give you an amount to use.

The wound paper calls the full natural protein beta-4.

Why don't KLOW peptide parts keep the same timing?

One mixed vial can't make the four levels match. Your body clears each peptide on its own clock.

  • KPV is a small three-part peptide. The kidneys likely clear it fast.
  • GHK-Cu is also small and may clear fast. We know it can pass through skin, but we don't know its timing after a shot.
  • BPC-157 lasted under ~30 minutes in rat blood. Rat studies often gave it more than once to keep some exposure.
  • TB-500 hasn't had a formal timing study as the short piece. The whole natural protein follows a different course.

Your blood may lose KPV and GHK-Cu within minutes or a few hours. BPC-157 also has a short window. You still don't know the timing of short TB-500. One dose may expose your body to each part at a different time. The four don't run on one clock. Their size and time in the blood differ.

Your body may clear each part at a different time. One vial can't set a safe schedule for you.

What can mixing and storage change?

The KLOW vial comes freeze-dried as powder. In lab work, staff add germ-limiting water before use. They then keep the mixed vial cold and use it within the set time for that study.

You also face a catch from the way copper can react. GHK-Cu holds copper as part of its make-up. Copper can react with other matter and may harm the other three peptides in a mixed vial. No test has shown whether that happens inside a KLOW vial. This is a possible risk, not a known product fault.

Research users most often talk about a shot under the skin. Separate studies also used GHK-Cu on skin, KPV and BPC-157 by mouth, and BPC-157 in a joint. Your body may take up each route in a different way.

For your safety, mixing still leaves unknowns. You can't tell how long the blend will stay sound.

The amounts can help you check a study claim. They still can't become your plan.